- Home
- STRO vs XBIT Comparison
STRO vs XBIT Comparison
Compare STRO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- XBIT
- Stock Information
- Founded
- STRO 2003
- XBIT 2005
- Country
- STRO United States
- XBIT United States
- Employees
- STRO N/A
- XBIT N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- XBIT Pharmaceuticals and Biotechnology
- Sector
- STRO Health Care
- XBIT Health Care
- Exchange
- STRO Nasdaq
- XBIT Nasdaq
- Market Cap
- STRO 76.5M
- XBIT 82.3M
- IPO Year
- STRO 2018
- XBIT 2015
- Fundamental
- Price
- STRO $0.91
- XBIT $2.64
- Analyst Decision
- STRO Hold
- XBIT
- Analyst Count
- STRO 7
- XBIT 0
- Target Price
- STRO $1.97
- XBIT N/A
- AVG Volume (30 Days)
- STRO 480.6K
- XBIT 64.2K
- Earning Date
- STRO 11-12-2025
- XBIT 11-12-2025
- Dividend Yield
- STRO N/A
- XBIT N/A
- EPS Growth
- STRO N/A
- XBIT N/A
- EPS
- STRO N/A
- XBIT N/A
- Revenue
- STRO $104,473,000.00
- XBIT N/A
- Revenue This Year
- STRO $65.48
- XBIT N/A
- Revenue Next Year
- STRO N/A
- XBIT N/A
- P/E Ratio
- STRO N/A
- XBIT N/A
- Revenue Growth
- STRO N/A
- XBIT N/A
- 52 Week Low
- STRO $0.52
- XBIT $2.50
- 52 Week High
- STRO $4.60
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- STRO 52.61
- XBIT 37.82
- Support Level
- STRO $0.84
- XBIT $2.63
- Resistance Level
- STRO $0.95
- XBIT $3.00
- Average True Range (ATR)
- STRO 0.06
- XBIT 0.13
- MACD
- STRO -0.00
- XBIT -0.00
- Stochastic Oscillator
- STRO 65.42
- XBIT 12.20
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.